ENDOCRINE 润色咨询

ENDOCRINE

出版年份：1994 年文章数：3008 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：9.6% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：甲状腺<br>经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：甲状腺肿瘤<br>经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=)]
    2024-03-10 Bandore 来自广东省

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向：甲状腺
    经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：甲状腺<br>经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：甲状腺肿瘤<br>经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=)]
    2024-04-03 1234456789 来自江苏省

    还没投

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：甲状腺<br>经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：甲状腺肿瘤<br>经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=)]
    2024-04-01 1234456789 来自江苏省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：在投中

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：甲状腺<br>经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：甲状腺肿瘤<br>经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=)]
    2024-03-12 ms2000000185262432 来自广西

    审稿速度:6.0 | 投稿命中率:5.0
    偏重的研究方向：甲状腺肿瘤
    经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：甲状腺<br>经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：甲状腺肿瘤<br>经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=)]
    2024-03-14 1234456789 来自江苏省

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：在投

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：甲状腺<br>经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：甲状腺肿瘤<br>经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=)]
    2024-03-06 1234456789 来自江苏省

    投稿命中率:25.0
    经验分享：在投

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：甲状腺<br>经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：甲状腺肿瘤<br>经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=)]
    2021-03-16 ms1000001155806208

    求该期刊的参考文献格式，谢谢！

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：甲状腺<br>经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：甲状腺肿瘤<br>经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=)]
    2023-09-03 ms3000000565671099 来自广东省

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向：内分泌
    经验分享：感觉主编权力挺大的，人也很好，不刁钻

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：甲状腺<br>经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：甲状腺肿瘤<br>经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=)]
    2021-08-24 张晗玉

    我现在已经投稿了快60天，一直显示Under Review，老天啊

    4

    展开4条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2192398, encodeId=9726219239850, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向：甲状腺<br>经验分享：12 月投稿，1 月返修，2 月发表。最后确认时可以选择非 oa，不用版面费，编辑人也很好，总体而言挺推荐的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/17d5b4b6ce8a46658d891ee8430d192f-qHBLJweRbHSY.jpg, createdBy=25008441399, createdName=Bandore, createdTime=Sun Mar 10 15:06:47 CST 2024, time=2024-03-10, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2196810, encodeId=2239219681076, content=还没投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Apr 03 17:05:30 CST 2024, time=2024-04-03, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2196466, encodeId=b04b2196466b9, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Mon Apr 01 15:37:07 CST 2024, time=2024-04-01, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192712, encodeId=f5bf2192e125f, content=审稿速度:6.0 | 投稿命中率:5.0<br>偏重的研究方向：甲状腺肿瘤<br>经验分享：去年十一月投的稿件了，期间有一位审稿人接受，最近又变成了最原始的状态，什么消息也没有，打算催稿了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=20, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e8336506161, createdName=ms2000000185262432, createdTime=Tue Mar 12 10:14:32 CST 2024, time=2024-03-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2193140, encodeId=b4f52193140ea, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Thu Mar 14 11:51:45 CST 2024, time=2024-03-14, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2191568, encodeId=6806219156815, content=投稿命中率:25.0<br>经验分享：在投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKsHXJofxYo70D3uIMmicmpQlVNHz6fdFJWhllceA0wwUGibDBeWrjEXI0juVZ5gyVQnHciaEqryZ0cA/132, createdBy=59005107960, createdName=1234456789, createdTime=Wed Mar 06 19:24:38 CST 2024, time=2024-03-06, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=948610, encodeId=20e894861076, content=求该期刊的参考文献格式，谢谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e1715443305, createdName=ms1000001155806208, createdTime=Tue Mar 16 11:18:12 CST 2021, time=2021-03-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2155917, encodeId=ec3d215591e1a, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向：内分泌<br>经验分享：感觉主编权力挺大的，人也很好，不刁钻, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee5f5492890, createdName=ms3000000565671099, createdTime=Sun Sep 03 21:01:23 CST 2023, time=2023-09-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1010892, encodeId=03d31010892fe, content=我现在已经投稿了快60天，一直显示Under Review，老天啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=216f5404986, createdName=张晗玉, createdTime=Tue Aug 24 09:55:33 CST 2021, time=2021-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=469956, encodeId=d68846995630, content=这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。 <br> <br> Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4. <br> <br> Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25. <br> <br> Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44. <br> 我们总结下来，用基础研究的方法做临床，就基本没问题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=322, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=endocrine, createdTime=Sun Dec 27 13:42:00 CST 2009, time=2009-12-27, status=1, ipAttribution=)]
    2009-12-27 endocrine

    这个杂志分数不高，老板与主编还认识，几乎成为我们的实验室专业户了。

    Gong H, Tang Z, Yang Y, Sun L, Zhang W, Wang W, Cui B, Ning G. A patient with pseudohypoaldosteronism type II caused by a novel mutation in WNK4 gene. Endocrine. 2008 Jun;33(3):230-4.

    Wang S, Mao C, Zhao Z, Gu Q, Jin M, Xiao Y, Jiang X, Zhao Y, Zhang Y, Ning G. Increased TTS abrogates IDO-mediated CD4(+) T cells suppression in patients with Graves' disease. Endocrine. 2009 Aug;36(1):119-25.

    Zhang YW, Jia HY, Hong J, Ge Y, Zhang HJ, Shen CF, Ye L, Cui B, Li XY, Gu WQ, Zhang YF, Wang WQ, Ning G. Clinical and genetic analysis for four Chinese families with Prader-Willi syndrome. Endocrine. 2009 Aug;36(1):37-44.
    我们总结下来，用基础研究的方法做临床，就基本没问题。

    3

    展开3条回复
共160条页码: 2/16页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分